1. Home
  2. PGEN vs DAO Comparison

PGEN vs DAO Comparison

Compare PGEN & DAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.12

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Youdao Inc. each representing one

DAO

Youdao Inc. each representing one

HOLD

Current Price

$11.28

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
DAO
Founded
1998
2006
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
PGEN
DAO
Price
$4.12
$11.28
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$8.33
N/A
AVG Volume (30 Days)
2.8M
50.4K
Earning Date
05-13-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
$12.24
Revenue Next Year
$81.04
$14.60
P/E Ratio
N/A
$72.35
Revenue Growth
N/A
N/A
52 Week Low
$1.23
$8.00
52 Week High
$5.47
$12.96

Technical Indicators

Market Signals
Indicator
PGEN
DAO
Relative Strength Index (RSI) 54.94 58.80
Support Level $3.91 $8.92
Resistance Level $4.31 $12.96
Average True Range (ATR) 0.19 0.88
MACD 0.00 0.08
Stochastic Oscillator 64.01 66.53

Price Performance

Historical Comparison
PGEN
DAO

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About DAO Youdao Inc. each representing one

Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.

Share on Social Networks: